By Rishika Sadam HYDERABAD (Reuters) -Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Obesity is defined by chronic low-grade inflammation in the body. Fat cells, particularly dysfunctional ones, release ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

A clinical psychologist details why people living with obesity need a safe conversation space that is encouraging, not ...

Women with higher levels of body fat sometimes struggle to conceive and can face greater health risks during pregnancy.

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...

A new algorithm enables smartwatch fitness trackers to more accurately monitor energy expenditure of people with obesity ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

Rybelsus, the oral form of Semaglutide launched by Novo Nordisk in January 2022, has grown from Rs 26 crore to Rs 412 crore, ...

Some patients are aiming to lower their BMIs in order to increase their fertility; others are aiming to manage BMI-related ...